The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABIOMED INC | COM | 003654100 | 364,181 | 890,309 | SH | SOLE | 890,309 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 25,207 | 1,650,780 | SH | SOLE | 1,650,780 | 0 | 0 | ||
AIMMUNE THERAPEUTICS INC | COM | 00900T107 | 37,155 | 1,381,759 | SH | SOLE | 1,381,759 | 0 | 0 | ||
ALDER BIOPHARMACEUTICALS INC | COM | 014339105 | 29,279 | 1,853,101 | SH | SOLE | 1,853,101 | 0 | 0 | ||
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 147,295 | 1,186,427 | SH | SOLE | 1,186,427 | 0 | 0 | ||
ALIGN TECHNOLOGY INC | COM | 016255101 | 63,161 | 184,607 | SH | SOLE | 184,607 | 0 | 0 | ||
ALIMERA SCIENCES INC | COM | 016259103 | 2,948 | 3,013,793 | SH | SOLE | 3,013,793 | 0 | 0 | ||
AMAG PHARMACEUTICALS INC | COM | 00163U106 | 65,146 | 3,340,806 | SH | SOLE | 3,340,806 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 96,350 | 6,168,347 | SH | SOLE | 6,168,347 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 240,156 | 2,549,431 | SH | SOLE | 2,549,431 | 0 | 0 | ||
CELGENE CORP | COM | 151020104 | 31,358 | 394,840 | SH | SOLE | 394,840 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 226,168 | 4,974,007 | SH | SOLE | 4,974,007 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 1,027 | 123,686 | SH | SOLE | 123,686 | 0 | 0 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 6,136 | 500,913 | SH | SOLE | 500,913 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 93,578 | 6,906,158 | SH | SOLE | 6,906,158 | 0 | 0 | ||
EXACT SCIENCES CORP | COM | 30063P105 | 18,733 | 313,320 | SH | SOLE | 313,320 | 0 | 0 | ||
GILEAD SCIENCES INC | COM | 375558103 | 12,461 | 175,900 | SH | SOLE | 175,900 | 0 | 0 | ||
HISTOGENICS CORP | COM | 43358V109 | 757 | 302,922 | SH | SOLE | 302,922 | 0 | 0 | ||
IDERA PHARMACEUTICALS INC | COM NEW | 45168K306 | 814 | 616,355 | SH | SOLE | 616,355 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 113,696 | 4,803,364 | SH | SOLE | 4,803,364 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 171,145 | 7,236,583 | SH | SOLE | 7,236,583 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 79,230 | 4,663,324 | SH | SOLE | 4,663,324 | 0 | 0 | ||
MELINTA THERAPEUTICS INC | COM | 58549G100 | 322 | 50,689 | SH | SOLE | 50,689 | 0 | 0 | ||
MOMENTA PHARMACEUTICALS INC | COM | 60877T100 | 37,496 | 1,833,532 | SH | SOLE | 1,833,532 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 16,086 | 1,103,325 | SH | SOLE | 1,103,325 | 0 | 0 | ||
RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 11,224 | 3,966,087 | SH | SOLE | 3,966,087 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 130,317 | 832,536 | SH | SOLE | 832,536 | 0 | 0 | ||
SHIRE PLC | SPONSORED ADR | 82481R106 | 32,275 | 191,200 | SH | SOLE | 191,200 | 0 | 0 | ||
SOPHIRIS BIO INC | COM NEW | 83578Q209 | 694 | 247,000 | SH | SOLE | 247,000 | 0 | 0 | ||
STAAR SURGICAL CO | COM PAR $0.01 | 852312305 | 109,169 | 3,521,565 | SH | SOLE | 3,521,565 | 0 | 0 | ||
SUNESIS PHARMACEUTICALS INC | COM PAR | 867328700 | 2,464 | 1,162,473 | SH | SOLE | 1,162,473 | 0 | 0 | ||
TREVENA INC | COM | 89532E109 | 491 | 341,300 | SH | SOLE | 341,300 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 183,895 | 1,625,234 | SH | SOLE | 1,625,234 | 0 | 0 | ||
VANDA PHARMACEUTICALS INC | COM | 921659108 | 79,166 | 4,155,670 | SH | SOLE | 4,155,670 | 0 | 0 | ||
WRIGHT MED GROUP N V | ORD SHS 0.03 PAR | N96617118 | 71,587 | 2,757,587 | SH | SOLE | 2,757,587 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 1,304 | 29,500 | SH | SOLE | 29,500 | 0 | 0 |